» Articles » PMID: 37205104

MIR222HG Attenuates Macrophage M2 Polarization and Allergic Inflammation in Allergic Rhinitis by Targeting the MiR146a-5p/TRAF6/NF-κB Axis

Overview
Journal Front Immunol
Date 2023 May 19
PMID 37205104
Authors
Affiliations
Soon will be listed here.
Abstract

Although M2 macrophages are involved in the orchestration of type 2 inflammation in allergic diseases, the mechanisms underlying non-coding RNA (ncRNA)-mediated macrophage polarization in allergic rhinitis (AR) have not been systematically understood. Here, we identified long non-coding RNA (lncRNA) MIR222HG as a key regulator of macrophage polarization and revealed its role in AR. Consistent with our bioinformatic analysis of GSE165934 dataset derived from the Gene Expression Omnibus (GEO) database, lncRNA-MIR222HG and murine mir222hg were downregulated in our clinical samples and animal models of AR, respectively. Mir222hg was upregulated in M1 macrophages and downregulated in M2 macrophages. The allergen-ovalbumin facilitated polarization of RAW264.7 cells to the M2 phenotype, accompanied by the downregulation of mir222hg expression in a dose-dependent manner. Mir222hg facilitates macrophage M1 polarization and reverses M2 polarization caused by ovalbumin. Furthermore, mir222hg attenuates macrophage M2 polarization and allergic inflammation in the AR mouse model. Mechanistically, a series of gain- and loss-of-function experiments and rescue experiments were performed to verify the role of mir222hg as a ceRNA sponge that adsorbed miR146a-5p, upregulated Traf6, and activated the IKK/IκB/P65 pathway. Collectively, the data highlight the remarkable role of MIR222HG in the modulation of macrophage polarization and allergic inflammation, as well as its potential role as a novel AR biomarker or therapeutic target.

Citing Articles

Exploring Advances in Natural Plant Molecules for Allergic Rhinitis Immunomodulation in Vivo and in Vitro.

Li B, Dong B, Xie L, Li Y Int J Gen Med. 2025; 18:529-565.

PMID: 39911299 PMC: 11796455. DOI: 10.2147/IJGM.S493021.


The role of natural products targeting macrophage polarization in sepsis-induced lung injury.

Li Y, Ai S, Li Y, Ye W, Li R, Xu X Chin Med. 2025; 20(1):19.

PMID: 39910395 PMC: 11800549. DOI: 10.1186/s13020-025-01067-4.


Vitamin D and allergic diseases.

Zhang P, Xu Q, Zhu R Front Immunol. 2024; 15:1420883.

PMID: 39026686 PMC: 11254667. DOI: 10.3389/fimmu.2024.1420883.


Advanced Immunomodulatory Biomaterials for Therapeutic Applications.

Park J, Kim D Adv Healthc Mater. 2024; 14(5):e2304496.

PMID: 38716543 PMC: 11834384. DOI: 10.1002/adhm.202304496.


Macrophage polarization: an important role in inflammatory diseases.

Luo M, Zhao F, Cheng H, Su M, Wang Y Front Immunol. 2024; 15:1352946.

PMID: 38660308 PMC: 11039887. DOI: 10.3389/fimmu.2024.1352946.


References
1.
Specjalski K, Jassem E . MicroRNAs: Potential Biomarkers and Targets of Therapy in Allergic Diseases?. Arch Immunol Ther Exp (Warsz). 2019; 67(4):213-223. PMC: 6597590. DOI: 10.1007/s00005-019-00547-4. View

2.
Han X, Krempski J, Nadeau K . Advances and novel developments in mechanisms of allergic inflammation. Allergy. 2020; 75(12):3100-3111. DOI: 10.1111/all.14632. View

3.
Das S, Mukherjee S, Ali N . Super enhancer-mediated transcription of miR146a-5p drives M2 polarization during Leishmania donovani infection. PLoS Pathog. 2021; 17(2):e1009343. PMC: 7943006. DOI: 10.1371/journal.ppat.1009343. View

4.
Olivieri F, Prattichizzo F, Giuliani A, Matacchione G, Rippo M, Sabbatinelli J . miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases. Ageing Res Rev. 2021; 70:101374. DOI: 10.1016/j.arr.2021.101374. View

5.
Wang Z, Liu F, Wei M, Qiu Y, Ma C, Shen L . Chronic constriction injury-induced microRNA-146a-5p alleviates neuropathic pain through suppression of IRAK1/TRAF6 signaling pathway. J Neuroinflammation. 2018; 15(1):179. PMC: 5994250. DOI: 10.1186/s12974-018-1215-4. View